Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer.
Thorac Cancer
; 13(23): 3322-3330, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-36239337
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Thorac Cancer
Year:
2022
Document type:
Article
Affiliation country:
South Korea
Country of publication:
Singapore